Today: 21 May 2026
Browse Category

NASDAQ:IONQ 1 February 2026 - 20 May 2026

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

Xanadu Quantum Technologies’ shares surged 20.4% to $14.13 Wednesday, rebounding after a sharp May decline. The company reported Q1 revenue of $2.83 million and a net loss of $20.6 million, with 43.3 million Class B shares outstanding and a prospectus covering up to 293.7 million more. Other quantum stocks also rose. Xanadu is in talks for up to $285 million in Canadian government support.
20 May 2026
··
IonQ Stock Jumps as SkyWater Vote Puts $1.8 Billion Quantum Deal on the Clock

IonQ Stock Jumps as SkyWater Vote Puts $1.8 Billion Quantum Deal on the Clock

IonQ shares rose 15.54% to $56.89 Monday after SkyWater Technology shareholders approved IonQ’s $1.8 billion acquisition. The vote clears a major hurdle, but the deal still needs regulatory approval. SkyWater shareholders will receive $15 in cash and $20 in IonQ stock per share. IonQ reported first-quarter revenue of $64.7 million, up 755% from a year earlier.
12 May 2026
····
IonQ Stock Surges As SkyWater Vote Clears Key Hurdle For $1.8 Billion Quantum Chip Deal

IonQ Stock Surges As SkyWater Vote Clears Key Hurdle For $1.8 Billion Quantum Chip Deal

IonQ shares rose 16% Monday after SkyWater Technology shareholders approved IonQ’s $1.8 billion acquisition of the chip foundry. SkyWater shares gained 2.4%. The deal, still subject to regulatory approval, would bring semiconductor manufacturing in-house for IonQ. SkyWater shareholders voted overwhelmingly in favor, with 32.6 million for and about 405,000 against.
11 May 2026
···
IonQ’s $1.8 Billion Quantum Chip Bet Just Cleared a Key Hurdle

IonQ’s $1.8 Billion Quantum Chip Bet Just Cleared a Key Hurdle

SkyWater Technology shareholders approved IonQ’s $1.8 billion acquisition, with 32.6 million shares voting in favor and about 405,000 opposed. The deal, announced in January, gives SkyWater holders $15 cash and $20 in IonQ stock per share. Closing is expected in Q2 or Q3 2026, pending regulatory approval. IonQ recently reported $64.7 million in first-quarter revenue and raised its 2026 forecast.
10 May 2026
···
IonQ Earnings Today: $500 Stock Talk Meets a Quantum Reality Check

IonQ Earnings Today: $500 Stock Talk Meets a Quantum Reality Check

IonQ will report first-quarter results after the market closes Wednesday, with analysts expecting revenue of $49.8 million and a loss of 46 cents per share. Shares rose 2.6% to $49.26 in morning trading, valuing the company at $14.5 billion. IonQ’s $1.8 billion SkyWater Technology acquisition remains pending regulatory and shareholder approval. The company launched a commercial InSAR satellite radar product on Monday.
6 May 2026
····
Quantum Stocks With Growth Potential in April-May 2026: 4 Names Facing a May Reality Check

Quantum Stocks With Growth Potential in April-May 2026: 4 Names Facing a May Reality Check

IonQ, Rigetti, and D-Wave will report earnings between May 6 and May 12, with investors watching revenue, bookings, and cash burn. IonQ shares last traded at $43.08, Rigetti at $16.39, D-Wave at $18.11, and Quantum Computing Inc. at $8.57, all with negative price-to-earnings ratios. IonQ announced a quantum-safe network project in Florida. The sector faces pressure from new IPOs and SPACs.
29 April 2026
····
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
16 April 2026
······
IonQ Stock Extends Rally After DARPA Win and Quantum Networking Breakthrough

IonQ Stock Extends Rally After DARPA Win and Quantum Networking Breakthrough

IonQ shares climbed 2.8% to $44.46 by midday Thursday after announcing a DARPA contract under the new HARQ program and linking two commercial quantum systems with photons. The company reported 2025 revenue of $130 million and projected up to $245 million for 2026. Peers Rigetti and D-Wave Quantum also gained after Nvidia launched new AI models for quantum calibration and error correction.
16 April 2026
··
D-Wave Quantum Stock Jumps Again as Nvidia Ising Launch and CEO Pitch Put QBTS Back in Focus

D-Wave Quantum Stock Jumps Again as Nvidia Ising Launch and CEO Pitch Put QBTS Back in Focus

D-Wave Quantum shares rose about 8% in premarket trading Wednesday after a 15.8% jump Tuesday, following Nvidia’s release of open-source quantum AI models. CEO Alan Baratz promoted D-Wave as a commercial quantum player at Washington events, while a new bearish note warned the stock trades ahead of fundamentals. IonQ and Rigetti also surged Tuesday. D-Wave reported 2025 revenue of $24.6 million and recent bookings over $32.8 million.
15 April 2026
·····
IonQ Revenue Surge Puts Quantum Stocks Back in Focus, but QTUM ETF Shows Why Hype May Be Ahead

IonQ Revenue Surge Puts Quantum Stocks Back in Focus, but QTUM ETF Shows Why Hype May Be Ahead

IonQ reported 2025 revenue of $130 million, far ahead of D-Wave’s $24.6 million and Rigetti’s $7.1 million. IonQ shares rose about 4% by midday Monday, with Rigetti and D-Wave also higher. The Defiance Quantum ETF (QTUM) gained over 2% and now holds more than $3.5 billion in assets, though its four U.S. quantum stocks make up less than 3% of the fund.
23 March 2026
···
Rigetti Computing Stock Price Falls as Investors Want Revenue, Not Just Quantum Progress

Rigetti Computing Stock Price Falls as Investors Want Revenue, Not Just Quantum Progress

Rigetti Computing shares fell 1.7% to $15.41 in late trading Thursday as investors trimmed exposure to quantum-computing stocks. The drop came despite Britain’s new £2 billion quantum initiative, which also failed to lift IonQ and D-Wave Quantum. Rigetti’s last update showed $7.1 million in 2023 revenue and a major India order due in late 2026. Traders await new catalysts as sector volatility persists.
20 March 2026
··
IonQ stock jumps nearly 22% after results; 2026 revenue outlook and SkyWater deal in focus

IonQ stock jumps nearly 22% after results; 2026 revenue outlook and SkyWater deal in focus

IonQ shares jumped 21.7% to $40.88 after reporting fourth-quarter revenue of $61.9 million and a 2026 forecast above expectations. Trading volume reached 66.4 million shares. The company aims for an operational 256-qubit system by late 2026 and announced quantum-secured links in Romania. Wall Street targets diverged, with price estimates ranging from $35 to $100.
27 February 2026
···
Quantum computing stocks rebound into holiday week as Rigetti swings back, earnings loom

Quantum computing stocks rebound into holiday week as Rigetti swings back, earnings loom

Quantum computing stocks closed higher Friday, with Rigetti up 7.2% and IonQ up 8.8%. TD Cowen downgraded Rigetti, citing funding needs and competition. U.S. markets close Monday for Presidents Day; IonQ and D-Wave report results later this month. Quantum Computing Inc completed its $97.5 million Luminar Semiconductor acquisition.
15 February 2026
····
Quantum computing stocks rally: IonQ, Rigetti, D-Wave, QUBT prices jump as traders look to the week ahead

Quantum computing stocks rally: IonQ, Rigetti, D-Wave, QUBT prices jump as traders look to the week ahead

Shares of U.S.-listed quantum computing firms surged Friday, with IonQ up 15% and Rigetti, D-Wave, and Quantum Computing Inc gaining 18–21% as tech stocks rallied. IonQ rebounded after a short-seller report and ahead of its Feb. 25 results. Quantum Computing Inc jumped after announcing a $110 million acquisition. Trading volume was heavy across the sector.
8 February 2026
···
Quantum computing stocks bounce hard: IonQ, Rigetti, D‑Wave rally as traders reset for a data-heavy week

Quantum computing stocks bounce hard: IonQ, Rigetti, D‑Wave rally as traders reset for a data-heavy week

IonQ, Rigetti, D‑Wave, and Quantum Computing Inc shares surged 15–21 percent Friday, erasing losses from the previous session. The rebound followed a Wall Street rally that sent the Dow above 50,000 for the first time. IonQ remains under scrutiny after a short-seller report questioned its Pentagon contract revenue. Investors await delayed U.S. jobs and inflation data next week.
7 February 2026
···
IonQ stock tumbles again as short-seller report hangs over quantum trade

IonQ stock tumbles again as short-seller report hangs over quantum trade

IonQ shares fell about 11% to $31.49 Thursday after Wolfpack Research released a short report questioning the company’s reliance on U.S. defense funding. IonQ denied the claims, calling them “false, misleading, and unsubstantiated.” Other quantum computing stocks, including Rigetti and D-Wave, also dropped sharply. Investors await IonQ’s February 25 earnings for further details.
5 February 2026
···
Quantum computing stocks: IonQ, Rigetti Computing, D-Wave Quantum slide 7%-9% — what to watch next week

Quantum computing stocks: IonQ, Rigetti Computing, D-Wave Quantum slide 7%-9% — what to watch next week

Quantum computing stocks fell sharply Friday, with IonQ down 7.5%, Rigetti 8.4%, D-Wave 8.6%, Quantum Computing Inc 9.0%, and Arqit Quantum 8.9%. IonQ disclosed share issuances tied to its Skyloom and Seed Innovations acquisitions in a recent SEC filing. U.S. markets are closed for the weekend. The Feb. 6 jobs report and Big Tech earnings are the next major events.
1 February 2026
····
1 2 3 … 6

Stock Market Today

  • Stocks Climb as Oil Prices and Treasury Yields Drop Ahead of Nvidia Earnings
    May 20, 2026, 6:04 PM EDT. U.S. stocks surged with the Dow Jones up 1.31%, S&P 500 gaining 1.08%, and Nasdaq rising 1.54% on May 20, 2026. This followed a sharp decline in oil prices, with WTI crude down 5.66% at $98.26 per barrel, and Brent crude falling 5.63%. Lower oil prices came after reports of progress in Middle East peace talks. Treasury yields eased, with the 10-year yield dropping over 9 basis points, alleviating recent inflation concerns. Market focus shifts to Nvidia's Q1 earnings report, seen as a critical indicator for the AI sector and chip demand. Nvidia shares rose over 1% ahead of results, trading near a 20% gain for the year. Analysts caution that while expectations are muted, the report could influence the broader market sentiment significantly.

Latest articles

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

20 May 2026
Xanadu Quantum Technologies’ shares surged 20.4% to $14.13 Wednesday, rebounding after a sharp May decline. The company reported Q1 revenue of $2.83 million and a net loss of $20.6 million, with 43.3 million Class B shares outstanding and a prospectus covering up to 293.7 million more. Other quantum stocks also rose. Xanadu is in talks for up to $285 million in Canadian government support.
MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
Go toTop